Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester
概述 用途与合成方法 MSDS Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester价格(试剂级) 上下游产品信息
| 中文名称 | Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester |
|---|---|
| 中文同义词 | 化合物LINAPRAZAN GLURATE;5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-A]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸 |
| 英文名称 | Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester |
| 英文同义词 | Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester;fast onset,Linaprazan glurate,gastric acid,gastrointestinal inflammatory diseases,peptic ulcer diseases,Inhibitor,inhibit;5-[2-[[[8-[(2,6-dimethylphenyl)methylamino]-2,3-dimethyl-6-imidazo[1,2-a]pyridinyl]-oxomethyl]amino]ethoxy]-5-oxopentanoic acid;5-(2-(8-((2,6-Dimethylbenzyl)amino)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamido)ethoxy)-5-oxopentanoic acid;Linaprazan glurate |
| CAS号 | 1228559-81-6 |
| 分子式 | C26H32N4O5 |
| 分子量 | 480.56 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 1228559-81-6.mol |
| 结构式 | ![Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester 结构式](CAS/20210111/GIF/1228559-81-6.gif) |
Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester 性质
| 密度 | 1.25±0.1 g/cm3(Predicted) |
|---|---|
| 储存条件 | Store at -20°C |
| 酸度系数(pKa) | 4.60±0.10(Predicted) |
| 形态 | 固体 |
| 颜色 | 白色至米白色 |
Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester 用途与合成方法
Linaprazan glurate 抑制外源性或内源性刺激的胃酸分泌。Linaprazan glurate 表现出几个有利的特性，例如起效快、体内效力高和/或作用持续时间长。Linaprazan glurate 可用于胃肠道炎症性疾病和消化性溃疡疾病的研究 (信息摘自专利 WO2010063876A1)。
安全信息
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026/09/15 | HY-145578 | Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester Linaprazan glurate | 1228559-81-6 | 5 mg | 520元 |
| 2026/09/15 | HY-145578 | Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester Linaprazan glurate | 1228559-81-6 | 10 mM * 1 mLin DMSO | 550元 |